Literature DB >> 16476853

Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines.

Ehrin J Armstrong1, David A Morrow, Marc S Sabatine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16476853     DOI： 10.1161/CIRCULATIONAHA.105.595520

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  35 in total

1.  Hsp 70, hsCRP and oxidative stress in patients with acute coronary syndromes.

Authors:  Ramazan Amanvermez; Ethem Acar; Murat Günay; Ahmet Baydın; Türker Yardan; Yüksel Bek
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 3.  Biomarkers of sleep apnea.

Authors:  Sydney B Montesi; Ednan K Bajwa; Atul Malhotra
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

4.  Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; György Haskó; Lucas Liaudet; Ken Mackie; Pál Pacher
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  Effects of antioxidant-rich foods on vascular reactivity: review of the clinical evidence.

Authors:  Colin D Kay; Penny M Kris-Etherton; Sheila G West
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

6.  The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.

Authors:  Judith J Lok; Peter W Hunt; Ann C Collier; Constance A Benson; Mallory D Witt; Amneris E Luque; Steven G Deeks; Ronald J Bosch
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

7.  Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.

Authors:  Wen Qiang Chen; Lin Zhong; Lei Zhang; Xiao Ping Ji; Mei Zhang; Yu Xia Zhao; Cheng Zhang; Yun Zhang
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

8.  Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy.

Authors:  Allison C Ross; Rachel Armentrout; Mary Ann O'Riordan; Norma Storer; Nesrine Rizk; Danielle Harrill; Dalia El Bejjani; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

9.  The Karachi intracranial stenosis study (KISS) Protocol: an urban multicenter case-control investigation reporting the clinical, radiologic and biochemical associations of intracranial stenosis in Pakistan.

Authors:  Ayeesha Kamran Kamal; Fawad Taj; Babar Junaidi; Asif Rasheed; Moazzam Zaidi; Muhammed Murtaza; Naved Iqbal; Fahad Hashmat; Syed Vaqas Alam; Uzma Saleem; Shahan Waheed; Lajpat Bansari; Nabi Shah; Maria Samuel; Madiha Yameen; Sobia Naz; Farrukh Shahab Khan; Naveeduddin Ahmed; Khalid Mahmood; Niaz Sheikh; Karim Ullah Makki; Muhammad Masroor Ahmed; Abdul Rauf Memon; Mohammad Wasay; Nadir Ali Syed; Bhojo Khealani; Philippe M Frossard; Danish Saleheen
Journal:  BMC Neurol       Date:  2009-07-15       Impact factor: 2.474

10.  Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.

Authors:  José A Páramo; José A Rodríguez Ja; Josune Orbe
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.